Interleukin-10-mediated inhibition of free radical generation in macrophages.

Interleukin-10 (IL-10) is a pleiotropic cytokine that controls inflammatory processes by suppressing the production of proinflammatory cytokines that are known to be transcriptionally regulated by nuclear factor-kappaB (NF-kappaB). Although still controversial, IL-10 has been shown to inhibit NF-kappaB activation through a process that involves proteolytic degradation of inhibitory subunit IkappaB-alpha. What is not known, however, is the mechanism by which IL-10 exerts its effect on IkappaB-alpha degradation. The present study investigates the possible role of reactive oxygen species (ROS) and their inhibition by IL-10 in NF-kappaB activation and IkappaB-alpha degradation in macrophages. Treatment of the cells with lipopolysaccharide (LPS) caused activation of NF-kappaB and rapid proteolysis of IkappaB-alpha as determined by the electrophoretic mobility shift assay, gene transfection, and Western blot. IL-10 pretreatment inhibited both NF-kappaB activation and IkappaB-alpha degradation. Both of these processes were also inhibited by ROS scavengers, catalase (H(2)O(2) scavenger), and sodium formate (.OH scavenger) but were minimally affected by superoxide dismutase (O scavenger). These results suggests that.OH radicals, formed by an H(2)O(2)-dependent, metal-catalyzed Fenton reaction, play a major role in this process. Electron spin resonance studies confirmed the formation of.OH radicals in LPS-treated cells. Addition of IL-10 inhibited both IkappaB-alpha degradation and generation of.OH radicals in response to LPS stimulation. These results demonstrate, for the first time, direct evidence for the role of IL-10 in ROS-dependent NF-kappaB activation.

[1]  G. Pierce.  Macrophages: important physiologic and pathologic sources of polypeptide growth factors. , 1990, American journal of respiratory cell and molecular biology.

[2]  B. Foxwell,et al.  IL‐10‐mediated suppression of TNF‐α production is independent of its ability to inhibit NFκB activity , 1998 .

[3]  J. Piette,et al.  Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1. , 2000, Biochemical pharmacology.

[4]  J. Vries.  Immunosuppressive and anti-inflammatory properties of interleukin 10. , 1995, Annals of medicine.

[5]  P. Tassone,et al.  IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes. , 1996, Journal of immunology.

[6]  B. Foxwell,et al.  IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity. , 1998, European journal of immunology.

[7]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[8]  P. Baeuerle,et al.  Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. , 1993, Nature.

[9]  T. Maniatis,et al.  Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. , 1997, Cell.

[10]  O. Martínez-Maza,et al.  Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. , 1996, Journal of immunology.

[11]  D. Baltimore,et al.  NF-κB Activation: The IκB Kinase Revealed? , 1997, Cell.

[12]  M. L. Karnovsky,et al.  Superoxide production by phagocytic leukocytes , 1975, The Journal of experimental medicine.

[13]  Xianglin Shi,et al.  The role of superoxide radical in TNF-alpha induced NF-kappaB activation. , 1999, Annals of clinical and laboratory science.

[14]  A. Baldwin,et al.  The NF-kappa B and I kappa B proteins: new discoveries and insights. , 1996, Annual review of immunology.

[15]  D. Baltimore,et al.  The involvement of NF-κB in β-interferon gene regulation reveals its role as widely inducible mediator of signal transduction , 1989, Cell.

[16]  W C Greene,et al.  NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. , 1993, Science.

[17]  G. Buettner.  The spin trapping of superoxide and hydroxyl free radicals with DMPO (5,5-dimethylpyrroline-N-oxide): more about iron. , 1993, Free radical research communications.

[18]  T. Maniatis,et al.  Activation of the IκBα Kinase Complex by MEKK1, a Kinase of the JNK Pathway , 1997, Cell.

[19]  M. Billah,et al.  Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. , 1995, The Journal of biological chemistry.

[20]  Richard D. Thompson,et al.  The transcriptional activator , 1996 .

[21]  A. Israël,et al.  I kappa B proteins: structure, function and regulation. , 1997, Seminars in cancer biology.

[22]  M. Mayo,et al.  Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. , 1999, The Journal of biological chemistry.

[23]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[24]  M. Mayo,et al.  Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding* , 1999, The Journal of Biological Chemistry.

[25]  G. Rosen,et al.  [23] Spin trapping of superoxide and hydroxyl radicals , 1984 .

[26]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[27]  E. Vellenga,et al.  Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-kappa B) which are involved in IL-6 regulation. , 1996, Leukemia.

[28]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[29]  M. Howard,et al.  Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice , 1994, The Journal of experimental medicine.

[30]  Peng Wang,et al.  Interleukin (IL)-10 Inhibits Nuclear Factor B (NFB) Activation in Human Monocytes , 1995, The Journal of Biological Chemistry.

[31]  Y. Rojanasakul,et al.  Mechanisms of hydroxyl free radical-induced cellular injury and calcium overloading in alveolar macrophages. , 1993, American journal of respiratory cell and molecular biology.

[32]  A. Baldwin,et al.  Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation , 1993, Molecular and cellular biology.

[33]  S. Gerstberger,et al.  Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation , 1995, Science.

[34]  J. Gee,et al.  Catalase-dependent peroxidative metabolism in the alveolar macrophage during phagocytosis. , 1970, The Journal of clinical investigation.

[35]  D. Baltimore,et al.  The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. , 1989, Cell.

[36]  A. Israël,et al.  IκB proteins: structure, function and regulation , 1997 .

[37]  Y. Ben-Neriah,et al.  Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB , 1993, Nature.

[38]  A. Bowie,et al.  Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. , 2000, Biochemical pharmacology.

[39]  P. Baeuerle.  Enter a polypeptide messenger , 1995, Nature.

[40]  M. Howard,et al.  Interleukin 10 protects mice from lethal endotoxemia , 1993, The Journal of experimental medicine.

[41]  T. Maniatis,et al.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. , 1995, Genes & development.

[42]  H. Pahl,et al.  Phosphorylation of human I kappa B‐alpha on serines 32 and 36 controls I kappa B‐alpha proteolysis and NF‐kappa B activation in response to diverse stimuli. , 1995, The EMBO journal.

[43]  D. Baltimore,et al.  NF-kappaB activation: the I kappaB kinase revealed? , 1997, Cell.

[44]  S. Masters,et al.  14-3-3 proteins: structure, function, and regulation. , 2000, Annual review of pharmacology and toxicology.